Statins beneficial for diabetics
This article was originally published in The Tan Sheet
Statin therapy is safe and cost-effective option for reducing the risk of major vascular events in patients with diabetes and should be considered for almost all diabetics, according to a meta-analysis by the Cholesterol Treatment Trialists' Collaborators. The study, which was published in The Lancet Jan. 12 and included 14 trials with 18,686 diabetics and 17,220 non-diabetics, found statin therapy in diabetics was associated with a 9 percent proportional reduction in all-cause mortality per mmol/L reduction in LDL cholesterol, and was associated with a statistically similar 13 percent reduction in all-cause mortality in those without diabetes...
You may also be interested in...
Fractyl Health closed a $100m financing round to support ongoing development of duodenal mucosal resurfacing (DMR) technology that addresses root causes of type 2 diabetes. CEO Harith Rajagopalan spoke of his hopes for the technology.
The ‘sea change’ inside White Oak should be seen as very encouraging for sponsors, FDA official says.
Foreign facility visits may take longer to reach usual levels because of the ongoing coronavirus outbreaks in other countries.